What Is-Nonprofit Foundation-Austin-Researching Type 1 Diabetes
Video Credits can be found here http://broadcaster.beazil.net/public/credits/youtube/videos/41923 Type 1 diabetes (T1D) kills the body’s beta cells that produce insulin which gives us the energy we need for everyday life. JDRF’s vision, the Beta Cell Restoration Program, will not only stop the autoimmune attack but also return the number of beta cells to a normal level. JDRF is developing vaccines that will re-train the immune system to eliminate autoimmunity and leave the beta cells alone. Type 1 diabetes (T1D) can occur in anyone—not just kids. If you or an adult you know has recently been diagnosed with T1D, check out the JDRF T1D Care Kit, a free resource containing information and tools to educate, support and inspire newly diagnosed adults. Austin plays host to vast recreational and outdoor activities well-suited to help students with learning disabilities, nonverbal learning disorder, ADD, Asperger’s, autism and other special needs develop their independent living skills. With sunshine more than 300 days per year, Austin offers College Living Experience (CLE) students access to the Texas Hill Country, a destination for people who love fishing, water sports, bike trails, ball fields and picnic areas. Downtown Austin, known as the Live Music Capital of the World, is host to a variety of music events throughout the year. Favorites include the South by Southwest entertainment conferences and the Austin City Limits Music Festival. The Texas capital is renowned for its cultural and civic attractions including the Long Center for the Performing Arts, the Lyndon Baines Johnson Library and Museum, and the Bob Bullock Texas History Museum. Since its founding more than 40 years ago by parents of children affected by type 1 diabetes, the Juvenile Diabetes Research Foundation (JDRF) has been committed to finding a cure for all those individuals living with the disease. Today, JDRF acknowledges that this commitment will not likely be fulfilled in the near term. Although our ultimate goal—curing type 1 diabetes—remains unchanged, we are equally committed to better treating and preventing the disease. These goals aim to ensure that both children and adults living with type 1 diabetes remain healthy so that they can fully benefit from a cure when it becomes available. JDRF focuses on supporting the development and delivery of new therapies and devices that will ease the daily burden and challenges of managing type 1 diabetes and on the prevention of diabetes complications. The Health Care and Social Assistance industry includes establishments and services such as:
hospitals, nursing and residential care facilities and out-patient care centres; offices of health practitioners (i.e. dentists, doctors, optometrists and chiropractors); medical and diagnostic laboratories; home health care services; ambulance services; social assistance services (i.e. for children, youth, the elderly, families); community food, housing, emergency and relief services; vocational rehabilitation services; and daycare services JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
To conclude, the main issues should be pointed out –
TRIAD Results,Diabetes Research,DKA,Autoantigen Specific Immune Therapies,Humalog,Health Care Providers,Diabetic Ketoacidosis,donate,dipeptidyl peptidase 4 inhibitors,Team Cure Diabetes,Estrogen in Type 1 Diabetes,International,Medical Research Council,Glucose,Translating Research Into Action for Diabetes Study,neonatal diabetes,funding research,insulinoma,insulin lispro,adult-onset diabetes,repaglinide,Basal Insulin,Research Pathways,connect,Top Research Highlights,T1D Team,insulin aspart,show your support,Premixed insulin,monogenic diabetes syndrome,Scientific,Grant Management Portal,Carol Lurie,The Hyperglycemia and Adverse Pregnancy Outcome Study,hyperosmolar hyperglycemic nonketotic syndrome,Diabetes and Pregnancy,diabetes care concepts,Global Diabetes Research,diabetes prevention program,diabetic kidney disease,Continuous glucose monitoring,borderline diabetes,Research Home,glucose tolerance,insulin pen,high blood glucose,acetohexamide,DILfrequency study,T1D management,Carb Counting,diabetic retinopathy,Intermediate Acting Insulin,The Action to Control Cardiovascular Risk in Diabetes.